Robotic surgery shows benefits for colon and rectal cancer patients

A retrospective analysis of over 52,000 patients revealed that robotic and laparoscopic surgeries significantly outperformed open surgery in achieving treatment goals (74.5% and 72.9% vs. 47.8%, p < 0.001) across all body mass index (BMI) categories. Robotic surgery also resulted in lower major morbidity rates compared to open surgery. Notably, rectal cancer patients with class II and III obesity exhibited similar major morbidity rates regardless of surgical approach, highlighting the robotic method's advantage.